Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition
Open Access
- 18 May 2006
- Vol. 106 (11), 2318-2326
- https://doi.org/10.1002/cncr.21863
Abstract
BACKGROUND Within the Dutch MRI Screening (MRISC) study, a Dutch multicenter screening study for hereditary breast cancer, the authors investigated whether previously reported increased diagnostic accuracy of magnetic resonance imaging (MRI) compared with mammography would be maintained during subsequent screening rounds. METHODS From November 1999 to October 2003, 1909 eligible women were included in the study. Screening parameters and tumor characteristics of different rounds were calculated and compared. The authors defined 3 different types of imaging screening rounds: first round in women never screened by imaging before, first round in women screened by imaging (mainly mammography) before, and subsequent rounds. RESULTS The difference in sensitivity for invasive cancers between mammography and MRI was largest in the first round of women previously screened with mammography (20.0 vs. 93.3%; P = .003), but also in subsequent rounds, there was a significant difference in favor of MRI (29.4 vs. 76.5%; P = .02). The difference in false-positive rate between mammography and MRI was also largest in the first round of women previously screened with mammography (5.5 vs. 14.0%; P<.001), and it remained significant in subsequent rounds (4.6 vs. 8.2%; P<.001). Screen-detected tumors were smaller and more often lymph node negative than symptomatic tumors in age-matched control patients, but no major differences in tumor stage were found between tumors detected at subsequent rounds compared with those in the first round. CONCLUSIONS In subsequent rounds, a significantly higher sensitivity and better discriminating capacity of MRI compared with mammography was maintained, and a favorable tumor stage compared with age-matched symptomatic controls. As results of these subsequent screening rounds were most predictive for long-term effects, the authors expect that this screening program will contribute to a decrease of breast cancer mortality in these high-risk women. Cancer 2006. © 2006 American Cancer Society.Keywords
Funding Information
- Dutch Health Insurance Council (OG 98-03)
This publication has 23 references indexed in Scilit:
- MRI Screening for Breast Cancer in Women with a Familial or Genetic PredispositionImaging Decisions MRI, 2005
- Surveillance of BRCA1 and BRCA2 Mutation Carriers With Magnetic Resonance Imaging, Ultrasound, Mammography, and Clinical Breast ExaminationJAMA, 2004
- Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic PredispositionThe New England Journal of Medicine, 2004
- Differential Value of Comparison with Previous Examinations in Diagnostic Versus Screening MammographyAmerican Journal of Roentgenology, 2002
- Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation CarriersJournal of Clinical Oncology, 2002
- Breast MR Imaging Screening in 192 Women Proved or Suspected to Be Carriers of a Breast Cancer Susceptibility Gene: Preliminary ResultsRadiology, 2000
- Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 European family cancer clinicsEuropean Journal of Cancer, 1998
- Likelihood Ratios for Modern Screening MammographyJAMA, 1996
- Nation‐wide breast cancer screening in the Netherlands: Support for breast‐cancer mortality reductionInternational Journal of Cancer, 1995
- COMPARATIVE PATHOLOGY OF PREVALENT AND INCIDENT CANCERS DETECTED BY BREAST SCREENING: Edinburgh Breast Screening ProjectThe Lancet, 1986